Stenocare (Denmark) Performance
| STENO Stock | DKK 2.04 0.14 7.37% |
The entity has a beta of -1.31, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Stenocare are expected to decrease by larger amounts. On the other hand, during market turmoil, Stenocare is expected to outperform it. Stenocare AS right now has a risk of 9.1%. Please validate Stenocare potential upside, and the relationship between the total risk alpha and kurtosis , to decide if Stenocare will be following its existing price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Stenocare AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, Stenocare is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
| Begin Period Cash Flow | 26.4 M | |
| Total Cashflows From Investing Activities | -2.5 M |
Stenocare |
Stenocare Relative Risk vs. Return Landscape
If you would invest 258.00 in Stenocare AS on September 3, 2024 and sell it today you would lose (54.00) from holding Stenocare AS or give up 20.93% of portfolio value over 90 days. Stenocare AS is generating 0.0083% of daily returns and assumes 9.1002% volatility on return distribution over the 90 days horizon. Simply put, 81% of stocks are less volatile than Stenocare, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Stenocare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Stenocare's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Stenocare AS, and traders can use it to determine the average amount a Stenocare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 9.0E-4
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | STENO |
Estimated Market Risk
| 9.1 actual daily | 81 81% of assets are less volatile |
Expected Return
| 0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Stenocare is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Stenocare by adding Stenocare to a well-diversified portfolio.
Stenocare Fundamentals Growth
Stenocare Stock prices reflect investors' perceptions of the future prospects and financial health of Stenocare, and Stenocare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Stenocare Stock performance.
| Return On Equity | -0.49 | |||
| Return On Asset | -0.28 | |||
| Operating Margin | (11.44) % | |||
| Current Valuation | 119.1 M | |||
| Shares Outstanding | 11.42 M | |||
| Price To Book | 4.21 X | |||
| Price To Sales | 67.34 X | |||
| EBITDA | (12.96 M) | |||
| Cash And Equivalents | 20.42 M | |||
| Cash Per Share | 1.79 X | |||
| Book Value Per Share | 2.40 X | |||
| Cash Flow From Operations | (13.34 M) | |||
| Earnings Per Share | (1.17) X | |||
| Total Asset | 43.94 M | |||
About Stenocare Performance
By analyzing Stenocare's fundamental ratios, stakeholders can gain valuable insights into Stenocare's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Stenocare has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Stenocare has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Stenocare AS cultivates, produces, imports, sells, and distributes prescription-based medical cannabis products in the Danish and European markets. The company was founded in 2017 and is headquartered in Allerd, Denmark. STENOCARE is traded on Copenhagen Stock Exchange in Denmark.Things to note about Stenocare AS performance evaluation
Checking the ongoing alerts about Stenocare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Stenocare AS help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Stenocare AS had very high historical volatility over the last 90 days | |
| Stenocare AS has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (12.73 M) with loss before overhead, payroll, taxes, and interest of (6.01 M). | |
| Stenocare AS has accumulated about 20.42 M in cash with (13.34 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.79. | |
| Roughly 39.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Stenocare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Stenocare's stock is overvalued or undervalued compared to its peers.
- Examining Stenocare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Stenocare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Stenocare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Stenocare's stock. These opinions can provide insight into Stenocare's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Stenocare Stock analysis
When running Stenocare's price analysis, check to measure Stenocare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stenocare is operating at the current time. Most of Stenocare's value examination focuses on studying past and present price action to predict the probability of Stenocare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stenocare's price. Additionally, you may evaluate how the addition of Stenocare to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |